Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Characteristics of Daily Walking Bouts as Valid and Reliable Indicators of Exercise Capacity in Pulmonary Arterial Hypertension: Insights From the Randomized Controlled Study With Selexipag (TRACE).
Journal: Pulmonary circulation
Published: September 18, 2024
Development of Imaging Endpoints for Clinical Trials in AL and ATTR Amyloidosis: Proceedings of the Amyloidosis Forum.
Journal: JACC. Cardiovascular imaging
Published: May 16, 2024
Advancing Transthyretin Amyloidosis Drug Development in an Evolving Treatment Landscape: Amyloidosis Forum Meeting Proceedings.
Journal: Advances in therapy
Published: February 29, 2024
Pathway for Development and Validation of Multi-domain Endpoints for Amyloid Light Chain (AL) Amyloidosis.
Journal: Therapeutic innovation & regulatory science
Published: July 28, 2023
Statistical power considerations in the use of win ratio in cardiovascular outcome trials.
Journal: Contemporary clinical trials
Published: September 01, 2022
Proposed Cardiac End Points for Clinical Trials in Immunoglobulin Light Chain Amyloidosis: Report From the Amyloidosis Forum Cardiac Working Group.
Journal: Circulation. Heart failure
Published: March 25, 2022
An electrocardiogram-based AI algorithm for early detection of pulmonary hypertension.
Journal: The European respiratory journal
Published: October 21, 2021
Long-term electrocardiographic safety monitoring in clinical drug development: A report from the Cardiac Safety Research Consortium.
Journal: American heart journal
Published: January 24, 2017
Exploring New Endpoints for Patients With Heart Failure With Preserved Ejection Fraction.
Journal: Circulation. Heart failure
Published: October 21, 2016
Developing New Treatments for Heart Failure: Focus on the Heart.
Journal: Circulation. Heart failure
Published: October 02, 2015
Site selection for heart failure clinical trials in the USA.
Journal: Heart failure reviews
Published: February 05, 2015
High- and low-dose oral delayed-release mesalamine in children with mild-to-moderately active ulcerative colitis.
Journal: Journal of pediatric gastroenterology and nutrition
Published: November 25, 2014
Last Updated: 09/26/2026